IOVA peer analysis
Iovance (IOVA) against its competitors: price, today's move, 1-year return and market value side by side.
IOVA and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALXO ALX Oncology | $1.22 | 0.00% | -21.29% | – |
| BNTX BioNTech | $87.77 | -0.45% | -16.15% | $22.15B |
| FATE Fate Therapeutics | $2.08 | -4.15% | 61.24% | $249.23M |
| GMAB Genmab | $55.53 | -2.67% | 93.70% | $35.09B |
| IBRX ImmunityBio | $8.10 | -2.35% | 243.01% | $8.79B |
| IMCR Immunocore | $30.00 | -1.61% | -6.80% | – |
| IMNM Immunome | $19.39 | 6.48% | 21.34% | – |
| LEGN Legend Biotech | $21.55 | -0.37% | -33.18% | $4.21B |
| REPL Replimune | $18.85 | 7.04% | 84.62% | $1.67B |
| STTK Shattuck Labs | $5.56 | -2.80% | 189.58% | – |
| IOVA Iovance | $7.91 | -6.72% | 305.64% | $3.84B |
- IOVA's peers: ALXO (ALX Oncology), BNTX (BioNTech), FATE (Fate Therapeutics), GMAB (Genmab), IBRX (ImmunityBio), IMCR (Immunocore), IMNM (Immunome), LEGN (Legend Biotech).
Updated 2026-11-02 18:28 UTC